Subclinical Atrial Fibrillation in Older Patients

被引:191
|
作者
Healey, Jeff S. [1 ,2 ]
Alings, Marco [3 ,4 ]
Ha, Andrew [5 ]
Leong-Sit, Peter [6 ]
Birnie, David H. [7 ]
de Graaf, Jacob J. [8 ]
Freericks, Michel [9 ]
Verma, Atul [5 ]
Wang, Jia [1 ,2 ]
Leong, Darryl [1 ,2 ]
Dokainish, Hisham [1 ,2 ]
Philippon, Francois [10 ]
Barake, Walid [11 ]
McIntyre, William F. [2 ]
Simek, Kim [1 ]
Hill, Michael D. [12 ]
Mehta, Shamir R. [1 ,2 ]
Carlson, Mark [13 ]
Smeele, Frank [14 ]
Pandey, A. Shekhar [2 ,15 ]
Connolly, Stuart J. [1 ,2 ]
机构
[1] Populat Hlth Res Inst, Hamilton, ON, Canada
[2] McMaster Univ, Hamilton, ON, Canada
[3] Amphia Ziekenhuis, Breda, Netherlands
[4] WCN Dutch Network Cardiovasc Res, Toronto, ON, Canada
[5] Univ Toronto, Toronto, ON, Canada
[6] Univ Western Ontario, London, ON, Canada
[7] Univ Ottawa, Heart Inst, Ottawa, ON, Canada
[8] Nij Smellinghe Hosp, Drachten, Netherlands
[9] Ikazia Ziekenhuis, Rotterdam, Netherlands
[10] Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada
[11] Univ Alberta, Edmonton, AB, Canada
[12] Univ Calgary, Calgary, AB, Canada
[13] St Jude Med, Sylmar, CA USA
[14] Slingeland Ziekenhuis, Doetinchem, Netherlands
[15] Cambridge Cardiac Care Ctr, Cambridge, ON, Canada
基金
加拿大健康研究院;
关键词
atrial fibrillation; monitoring; physiologic; stroke; RISK; STROKE;
D O I
10.1161/CIRCULATIONAHA.117.028845
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Long-term continuous electrocardiographic monitoring shows a substantial prevalence of asymptomatic, subclinical atrial fibrillation (SCAF) in patients with pacemakers and patients with cryptogenic stroke. Whether SCAF is also common in other patients without these conditions is unknown. METHODS: We implanted subcutaneous electrocardiographic monitors (St. Jude CONFIRM-AF) in patients >= 65 years of age attending cardiovascular or neurology outpatient clinics if they had no history of atrial fibrillation but had any of the following: CHA(2)DS(2)-VASc score of >= 2, sleep apnea, or body mass index > 30 kg/m(2). Eligibility also required either left atrial enlargement (>= 4.4 cm or volume >= 58 mL) or increased (>= 290 pg/mL) serum NT-proBNP (N-terminal pro-B-type natriuretic peptide). Patients were monitored for SCAF lasting >= 5 minutes. RESULTS: Two hundred fifty-six patients were followed up for 16.3 +/- 3.8 months. Baseline age was 74 +/- 6 years; mean CHA(2)DS(2)-VASc score was 4.1 +/- 1.4; left atrial diameter averaged 4.7 +/- 0.8 cm; and 48% had a prior stroke, transient ischemic attack, or systemic embolism. SCAF >= 5 minutes was detected in 90 patients (detection rate, 34.4%/y; 95% confidence interval [CI], 27.7-42.3). Baseline predictors of SCAF were increased age (hazard ratio [HR] per decade, 1.55; 95% CI, 1.11-2.15), left atrial dimension (HR per centimeter diameter, 1.43; 95% CI, 1.09-1.86), and blood pressure (HR per 10 mm Hg, 0.87; 95% CI, 0.78-0.98), but not prior stroke. The rate of occurrence of SCAF in those with a history of stroke, systemic embolism, or transient ischemic attack was 39.4%/y versus 30.3%/y without (P=0.32). The cumulative SCAF detection rate was higher (51.9%/y) in those with left atrial volume above the median value of 73.5 mL. CONCLUSIONS: SCAF is frequently detected by continuous electrocardiographic monitoring in older patients without a history of atrial fibrillation who are attending outpatient cardiology and neurology clinics. Its clinical significance is unclear.
引用
收藏
页码:1276 / +
页数:12
相关论文
共 50 条
  • [1] Prevalence and predictors of subclinical atrial fibrillation in hospitalized older adults
    Spannella, Francesco
    Giulietti, Federico
    Pimpini, Lorenzo
    Lombardi, Francesca Elena
    Re, Serena
    Schiavi, Paola
    Dragano, Gina
    Antonicelli, Roberto
    Sarzani, Riccardo
    AGING-US, 2021, 13 (13): : 17024 - 17037
  • [2] Heartbeat: Diagnosis of subclinical atrial fibrillation by physicians and patients
    Otto, Catherine M.
    HEART, 2019, 105 (11) : 809 - 811
  • [3] Apixaban for Prevention of Stroke in Patients with subclinical Atrial Fibrillation
    Dovjak, Peter
    ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, 2024, 57 (05): : 412 - 412
  • [4] Should Patients with Subclinical Atrial Fibrillation Receive Anticoagulation?
    Reiffel, James A.
    Kowey, Peter R.
    Naccarelli, Gerald, V
    AMERICAN JOURNAL OF MEDICINE, 2024, 137 (05): : 383 - 385
  • [5] Apixaban for the Prevention of Stroke in Patients With Subclinical Atrial Fibrillation
    Healey, Jeff S.
    Lopes, Renato D., Sr.
    Granger, Christopher
    Alings, Marco
    Birnie, David H.
    Benezet-Mazuecos, Juan
    Nielsen, Jens Cosedis
    Boriani, Giuseppe
    Mairesse, Georges
    Hohnloser, Stefan H.
    Philippon, Francois
    Kutyifa, Valentina
    Gold, Michael R.
    Linde, Cecilia M.
    Conen, David
    Erath, Julia
    Mabo, Philippe
    Sticherling, Christiab
    Wright, David
    McIntyre, William F.
    Atar, Dan
    Mian, Rajibul
    Xu, Lizhen
    Rivard, Lena
    Kautzner, Josef
    Proietti, Marco
    Camm, Alan J.
    Aronson, Ronald
    Zarraga, Ignatius
    Ip, John
    Connolly, Stuart J.
    CIRCULATION, 2023, 148 (25) : E290 - E290
  • [6] The atrial vulnerability parameters of lone atrial fibrillation patients with subclinical hypothyroidism
    Komiya, N.
    Seto, S.
    Fukae, S.
    CIRCULATION, 2008, 118 (12) : E259 - E259
  • [7] The atrial vulnerability parameters in lone atrial fibrillation patients with subclinical hypothyroidism
    Komiya, N.
    Seto, S.
    Fukae, S.
    EUROPEAN HEART JOURNAL, 2008, 29 : 545 - 545
  • [8] Subclinical hyperthyroidism and atrial fibrillation
    Sawin, CT
    THYROID, 2002, 12 (06) : 501 - 503
  • [9] Subclinical Atrial Fibrillation: To Anticoagulate or Not?
    Kommu, Sharath
    Sharma, Param P.
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (11)
  • [10] Subclinical hyperthyroidsm and atrial fibrillation
    Auer, J
    Eber, B
    ACTA MEDICA AUSTRIACA, 2003, 30 (04) : 98 - 99